- Home
- NESR vs ABUS Comparison
NESR vs ABUS Comparison
Compare NESR & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NESR
- ABUS
- Stock Information
- Founded
- NESR 2017
- ABUS 2005
- Country
- NESR United States
- ABUS United States
- Employees
- NESR N/A
- ABUS N/A
- Industry
- NESR
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- NESR
- ABUS Health Care
- Exchange
- NESR NYSE
- ABUS Nasdaq
- Market Cap
- NESR 597.0M
- ABUS 611.0M
- IPO Year
- NESR N/A
- ABUS N/A
- Fundamental
- Price
- NESR $6.42
- ABUS $3.22
- Analyst Decision
- NESR Strong Buy
- ABUS Strong Buy
- Analyst Count
- NESR 5
- ABUS 4
- Target Price
- NESR $14.20
- ABUS $5.50
- AVG Volume (30 Days)
- NESR 1.2M
- ABUS 766.0K
- Earning Date
- NESR 08-11-2025
- ABUS 08-04-2025
- Dividend Yield
- NESR N/A
- ABUS N/A
- EPS Growth
- NESR 214.19
- ABUS N/A
- EPS
- NESR 0.80
- ABUS N/A
- Revenue
- NESR $1,307,958,000.00
- ABUS $6,403,000.00
- Revenue This Year
- NESR $6.09
- ABUS $3.35
- Revenue Next Year
- NESR $8.33
- ABUS N/A
- P/E Ratio
- NESR $8.01
- ABUS N/A
- Revenue Growth
- NESR 11.45
- ABUS N/A
- 52 Week Low
- NESR $5.20
- ABUS $2.71
- 52 Week High
- NESR $9.89
- ABUS $4.73
- Technical
- Relative Strength Index (RSI)
- NESR N/A
- ABUS 48.90
- Support Level
- NESR N/A
- ABUS $3.08
- Resistance Level
- NESR N/A
- ABUS $3.30
- Average True Range (ATR)
- NESR 0.00
- ABUS 0.10
- MACD
- NESR 0.00
- ABUS 0.01
- Stochastic Oscillator
- NESR 0.00
- ABUS 50.00
About NESR NATIONAL ENERGY SVCS REUNITED CORP
National Energy Services Reunited Corp is a British Virgin Islands-based company engaged in providing products and services to the oil and gas industry in the Middle East and North Africa and the Asia Pacific regions. The company has two reportable segments: Production Services including coil tubing, stimulation, and pumping, nitrogen services, completions, pipelines, cementing, laboratory services and filtration services; and Drilling and Evaluation Services including drilling and workover rigs, rig services, services, and well-testing services among others. Revenues are majorly derived from production services of an oil or natural gas well. It derives maximum revenue from Production services segment.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.